Erythrocyte-methotrexate and disease activity in children treated with oral methotrexate for juvenile chronic arthritis

Scandinavian Journal of Rheumatology

Volumn 29, Issue 3, 2000, Pages 187-189

  Kristensen, K ^a   Nielsen, S ^a   Pedersen, F K ^a   Zak, M ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Juvenile chronic arthritis; Methotrexate; Therapeutic drug monitoring

Indexed keywords

C REACTIVE PROTEIN; METHOTREXATE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE ACTIVITY; DOSE RESPONSE; DRUG ERYTHROCYTE LEVEL; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LABORATORY TEST; LEUKOCYTE COUNT; PRIORITY JOURNAL; SCORING SYSTEM;

ADMINISTRATION, ORAL; ADOLESCENT; ALANINE TRANSAMINASE; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; ERYTHROCYTES; HUMANS; LEUKOCYTE COUNT; METHOTREXATE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 0034541414     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/030097400750002085     Document Type: Article

References (11)

1. Comparative efficacy and safety of advanced drug therapy in children juvenile rheumatoid arthritis
2. Preliminary report of higher dose Methotrexate treatment in juvenile rheumatoid arthritis
3. Morbidity associated with long-term methotrexate therapy in juvenile rheumatoid arthritis
4. Plasma levels after oral methotrexate in children with juvenile rheumatoid arthrititis
5. For the Nordic Society for Pediatric Hematology and Oncology. Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance chemotherapy
6. Chronic arthritis in childhood
7. A rapid radiochemical-ligand binding assay for metothrexate
8. Pharmacokinetics of erythrocyte methotrexate after high-dose methotrexate
9. Assessment methods of disease activity in juvenile rheumatoid arthritis - Evaluated in a prednisolone /placebo double-blind study
10. Pharmaco-kinetics of erythrocyte methotrexate in children with acute lymphoblastic leukemia during maintenance treatment
11. Maintenance chemotherapy for childhood acute lymphoblastic leukemia: Should dosage be guided by white cell counts?